No Job Openings Found For Abraxis BioScience
Jobs by
Latest $100K+ Job Openings in California
| City | Title | Compensation |
|---|---|---|
| Los Angeles |
Account Executive - Global Accounts We are a global provider of on-demand business process improvement solutions. Our on-demand Communications Operating System offers business... |
$130K+ |
| San Diego |
Trauma Sales Associate (2009847) Have you always wanted to make a difference in peoples’ lives Would you like to have the backing of a global, fast moving innovative 150 ye... |
$100K+ |
| San Francisco |
Regional Sales Director, Enterprise Sales Job Code: RSD-TBAReports to: GM, Enterprise SalesLocation: To be determined, with regional territory in nearby area** NOTE: Principal... |
$200K |
| San Jose |
Regional Sales Director Our client, a leading Global provider of B2B Outsourcing services and Supply Chain solutions is looking for an experienced sales leader in San Jo... |
$325K |
| Sunnyvale |
Sr. Business Development Manager - ERP / SAP Business Development Manager :Business Development Manager with strong sales experience of selling ERP / SAP services;in North America.The person... |
$250K |
 | ||
Interview Tip
-
Abraxis' ABRAXANE gets FDA Orphan Drug status for treatment of pancreatic cancer, stage IIB-IV melanoma(06 Nov 2009 03:07:00 EST)6 November 2009 - US biotechnology company Abraxis BioScience Inc said yesterday that the US Food and Drug Administration has granted Orphan Drug designation to the chemotherapy agent ABRAXANE for Injectable Suspension for the treatment of pancreatic cancer and stage IIB-IV melanoma.
-
Other News To Note [BioWorld Today](06 Nov 2009 00:01:00 EST)• Abraxis BioScience Inc., of Los Angeles, said that the FDA granted orphan drug designation to the chemotherapy agent Abraxane for injectable suspension for the treatment of pancreatic cancer as well as stage IIB-IV melanoma. • Aeolus Pharmaceuticals Inc., of Mission Viejo, Calif., said AEOL 10150 has shown potential as a medical countermeasure to treat radiological and chemical threats.
-
Abraxis Health dedicates new biopharma manufacturing plant in Phoenix, Arizona(05 Nov 2009 03:44:00 EST)Abraxis Health, a personalised healthcare division of Abraxis BioScience Inc, said on Wednesday that it has dedicated its new nanotechnology and biologics facility in Phoenix, Arizona. Abraxis is investing USD70m in the new plant and it will create up to 200 high-tech jobs. The site in Phoenix was formerly owned by Watson Pharmaceuticals.
